Publications and ressources

Repurposing of the multiciliation gene regulatory network in fate specification of Cajal-Retzius neurons

Matthieu Moreau, Yoann Saillour, Vicente Elorriaga, Amaia OCHANDORENA SAA , Alessandra Pierani, Frédéric Causeret

Source : Dev Cell

2023 Jun 14

Pmid : 37321213

Diversity within olfactory sensory derivatives revealed by the contribution of Dbx1 lineages

Frédéric Causeret, Alessandra Pierani

Source : J Comp Neurol

2023 May 1

Pmid : 37125418

Aberrant survival of hippocampal Cajal-Retzius cells leads to memory deficits, gamma rhythmopathies and susceptibility to seizures in adult mice

Alessandra Pierani, Martina Riva, Patrick Azzam, Francesco Dori

Source : Nat Commun

2023 Mar 18

Pmid : 36934089

Activation of the PI3K/AKT/mTOR Pathway in Cajal-Retzius Cells Leads to Their Survival and Increases Susceptibility to Kainate-Induced Seizures

Nasim Ramezanidoraki, Driss EL-OUARDI, Nadia Bahi-Buisson, Alessandra Pierani, Pierre Billuart

Source : Int J Mol Sci

2023 Mar 11

Pmid : 36982451

Human genetic and immunological determinants of critical COVID-19 pneumonia.

Qian Zhang, Paul Bastard, Aurélie Cobat, Jean-Laurent CASANOVA , Anna-Lena Neehus, Anne Puel, Bertrand Boisson, Daniela Matuozzo, Emmanuelle Jouanguy, Jean-Laurent CASANOVA , Jérémie Rosain, Jeremy Manry, Laurent Abel , Lucia Victoria Erazo, Quentin Philippot, Romain Levy, Shen-Ying Zhang, Stéphanie Boisson-Dupuis, Tom Le Voyer, Vivien Beziat

Source : Nature

2022 Jan 28

Pmid : 35090163

Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges.

Annarita Miccio , Panagiotis Antoniou, Sorana CIURA, Edor Kabashi

Source : Mol Ther

2022 Jan 5

Pmid : 33823304

Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity.

Source : J Eur Acad Dermatol Venereol

2022 Jan 1

Pmid : 34543471

Trial of Spesolimab for Generalized Pustular Psoriasis.

Hervé Bachelez

Source : N Engl J Med

2021 Dec 23

Pmid : 34936739

Trial of Spesolimab for Generalized Pustular Psoriasis.

Hervé Bachelez

Source : N Engl J Med

2021 Dec 23

Pmid : 34936739

Drug Repurposing Reveals mTOR Inhibition as a Promising Strategy for Epidermolysis Bullosa Simplex.

Hélène Ragot, Alain Hovnanian

Source : J Invest Dermatol

2021 Dec 16

Pmid : 34924185

A CBF decrease in the left supplementary motor areas: New insight into postoperative pediatric cerebellar mutism syndrome using arterial spin labeling perfusion MRI.

Jennifer Boisgontier, Ludovic Fillon, Caroline Rutten , Ana Saitovitch, Hervé Lemaître, Thomas Blauwblomme, Alice Vinçon-Leite, Monica Zilbovicius , Nathalie Boddaert

Source : J Cereb Blood Flow Metab

2021 Dec 1

Pmid : 34259072

Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.

Baptiste LAMARTHÉE, Soëli CHARBONNIER, Tifanie BLEIN, Emmanuel Martin, Matthias Titeux, Marianne DELVILLE, Hélène VINÇON, Emmanuelle SIX, Sylvain Latour, Marina Cavazzana, Isabelle André, Julien ZUBER

Source : Nat Commun

2021 Nov 8

Pmid : 34750385

Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.

Hervé Bachelez

Source : J Allergy Clin Immunol

2021 Oct 20

Pmid : 34678325

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A.

Alice Lepelley, Marie-Louise Frémond, Luís Seabra, Yanick Crow

Source : The journal of experimental medicine 2021

2021 Oct 4

Pmid : 34387651

SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.

Hervé Bachelez

Source : J Clin Immunol

2021 Oct 1

Pmid : 34176064